Related Experiment Video
Updated: Nov 23, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
The emerging role of small non-coding RNA in renal cell carcinoma
Lifeng Ding1, Minxiao Jiang1, Ruyue Wang1
1Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
Abstract:
Noncoding RNAs are transcribed in the most regions of the human genome, divided into small noncoding RNAs (less than 200 nt) and long noncoding RNAs (more than 200 nt) according to their size. Compelling evidences suggest that small noncoding RNAs play critical roles in tumorigenesis and tumor progression, especially in renal cell carcinoma. MiRNA, the most famous small noncoding RNA, has been comprehensively explored for its fundamental role in cancer. And several miRNA-based therapeutic strategies have been applied to several ongoing clinical trials. However, piRNAs and tsRNAs, have not received as much research attention, because of several technological limitations. Nevertheless, some studies have revealed the presence of aberration of piRNAs and tsRNAs in renal cell carcinoma, highlighting a potentially novel mechanism for tumor onset and progression. In this review, we provide an overview of three classes of small noncoding RNA: miRNAs, piRNAs and tsRNAs, that have been reported dysregulation in renal cell carcinoma and have the potential for advancing diagnosis, prognosis and therapeutic applications of this disease.
Insights
Small noncoding RNAs, including microRNAs (miRNAs), piwi-interacting RNAs (piRNAs), and tRNA-derived small RNAs (tsRNAs), are implicated in renal cell carcinoma. Dysregulation of these molecules offers potential for improved diagnosis and treatment.
Area of Science:
- Molecular Biology
- Genomics
- Oncology
Background:
- Noncoding RNAs are crucial genomic elements, categorized by size into small (sncRNAs) and long (lncRNAs).
- Small noncoding RNAs, particularly microRNAs (miRNAs), are extensively studied for their roles in cancer, including renal cell carcinoma (RCC).
- Piwi-interacting RNAs (piRNAs) and tRNA-derived small RNAs (tsRNAs) are less explored but show aberrations in RCC, suggesting novel roles in tumorigenesis.
Purpose of the Study:
- To review the roles of three classes of small noncoding RNAs—miRNAs, piRNAs, and tsRNAs—in renal cell carcinoma.
- To highlight the dysregulation of these small noncoding RNAs in RCC.
- To discuss their potential for advancing diagnosis, prognosis, and therapeutic strategies for RCC.
Main Methods:
- Literature review of studies on small noncoding RNAs in renal cell carcinoma.
- Analysis of current research on miRNA, piRNA, and tsRNA dysregulation in RCC.
- Synthesis of findings regarding the diagnostic, prognostic, and therapeutic potential.
Main Results:
- MicroRNAs are well-established players in RCC, with therapeutic strategies in clinical trials.
- PiRNAs and tsRNAs, despite technological challenges, exhibit aberrations in RCC, indicating their involvement in tumor development.
- Dysregulated small noncoding RNAs present novel mechanisms for RCC onset and progression.
Conclusions:
- Small noncoding RNAs, including miRNAs, piRNAs, and tsRNAs, are significantly dysregulated in renal cell carcinoma.
- These molecules hold promise as biomarkers for diagnosis and prognosis.
- Targeting small noncoding RNAs represents a potential therapeutic avenue for renal cell carcinoma.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

